Drugs and treatment stories

In a this blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. This is the final part where the results of the trial are in...

Maria was diagnosed with relapsing remitting MS last June. Here she shares her experience of choosing a disease modifying drug. "It’s scary being asked to make such a massive decision, so if you do feel afraid, that’s normal," Maria tells us. 

What do you do when the disease modifying drug (DMD) you've chosen isn't working? In this guest blog, Lauren shares her thoughts around choosing an MS treatment and what it is like having to change to a new one. 

Kate guest blogs about her experiences taking part in a clinical trial for the drug bexarotene. 

Choosing a disease modifying drug (DMD) is an individual decision and it can be important to weigh up your options and think about what might work best for you. In this guest blog, Toni shares her experiences of choosing an MS treatment and explains what it was like to start on Plegridy. 

Choosing which disease modifying drug (DMD) to start is not always easy and sometimes you'll find that you don't get on with the drug you have chosen. In this guest blog, Jane shares her experience of making a decision about treatment.